Literature DB >> 21355625

Analysis of Leishmania chagasi by 2-D difference gel electrophoresis (2-D DIGE) and immunoproteomic: identification of novel candidate antigens for diagnostic tests and vaccine.

Míriam M Costa1, Hélida M Andrade, Daniella C Bartholomeu, Leandro M Freitas, Simone F Pires, Alexander D Chapeaurouge, Jonas Perales, André T Ferreira, Mário S Giusta, Maria N Melo, Ricardo T Gazzinelli.   

Abstract

Identification of novel antigens is essential for developing new diagnostic tests and vaccines. We used DIGE to compare protein expression in amastigote and promastigote forms of Leishmania chagasi. Nine hundred amastigote and promastigote spots were visualized. Five amastigote-specific, 25 promastigote-specific, and 10 proteins shared by the two parasite stages were identified. Furthermore, 41 proteins were identified in the Western blot employing 2-DE and sera from infected dogs. From these proteins, 3 and 38 were reactive with IgM and total IgG, respectively. The proteins recognized by total IgG presented different patterns in terms of their recognition by IgG1 and/or IgG2 isotypes. All the proteins selected by Western blot were mapped for B-cell epitopes. One hundred and eighty peptides were submitted to SPOT synthesis and immunoassay. A total of 25 peptides were shown of interest for serodiagnosis to visceral leishmaniasis. In addition, all proteins identified in this study were mapped for T cell epitopes by using the NetCTL software, and candidates for vaccine development were selected. Therefore, a large-scale screening of L. chagasi proteome was performed to identify new B and T cell epitopes with potential use for developing diagnostic tests and vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355625     DOI: 10.1021/pr101286y

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  19 in total

Review 1.  A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.

Authors:  Daniela P Lage; Vívian T Martins; Mariana C Duarte; Lourena E Costa; Esther Garde; Laura M Dimer; Amanda C S Kursancew; Miguel A Chávez-Fumagalli; Danielle F de Magalhães-Soares; Daniel Menezes-Souza; Bruno M Roatt; Ricardo A Machado-de-Ávila; Manuel Soto; Carlos A P Tavares; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2016-01-19       Impact factor: 2.289

2.  An immunoproteomic approach to identifying immunoreactive proteins in Leishmania infantum amastigotes using sera of dogs infected with canine visceral leishmaniasis.

Authors:  Sajad Rashidi; Zahra Mojtahedi; Bahador Shahriari; Kurosh Kalantar; Ghasem Ghalamfarsa; Mehdi Mohebali; Gholamreza Hatam
Journal:  Pathog Glob Health       Date:  2019-05-17       Impact factor: 2.894

3.  Epitope mapping of the HSP83.1 protein of Leishmania braziliensis discloses novel targets for immunodiagnosis of tegumentary and visceral clinical forms of leishmaniasis.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Matheus de Souza Gomes; João Luís Reis-Cunha; Ronaldo Alves Pinto Nagem; Cláudia Martins Carneiro; Eduardo Antônio Ferraz Coelho; Lúcia Maria da Cunha Galvão; Ricardo Toshio Fujiwara; Daniella Castanheira Bartholomeu
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

Review 4.  Understanding Leishmania parasites through proteomics and implications for the clinic.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Proteomics       Date:  2018-05-02       Impact factor: 3.940

5.  Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2-Based Protein for Human Visceral Leishmaniasis Diagnosis.

Authors:  Maria Marta Figueiredo; Anna R R Dos Santos; Lara C Godoi; Natália S de Castro; Bruno C de Andrade; Sarah A R Sergio; Selma M B Jerônimo; Edward J de Oliveira; Ruth T Valencia-Portillo; Lucilândia M Bezerra; Hiro Goto; Maria C A Sanchez; Caroline Junqueira; Santuza M R Teixeira; Flávio G da Fonseca; Ricardo T Gazzinelli; Ana Paula Fernandes
Journal:  J Immunol Res       Date:  2021-04-28       Impact factor: 4.818

6.  High-throughput analysis of synthetic peptides for the immunodiagnosis of canine visceral leishmaniasis.

Authors:  Angélica R Faria; Míriam M Costa; Mário S Giusta; Gabriel Grimaldi; Marcus L O Penido; Ricardo T Gazzinelli; Hélida M Andrade
Journal:  PLoS Negl Trop Dis       Date:  2011-09-13

Review 7.  Advances in Development of New Treatment for Leishmaniasis.

Authors:  Juliana Perrone Bezerra de Menezes; Carlos Eduardo Sampaio Guedes; Antônio Luis de Oliveira Almeida Petersen; Deborah Bittencourt Mothé Fraga; Patrícia Sampaio Tavares Veras
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

8.  Mapping B-cell epitopes for the peroxidoxin of Leishmania (Viannia) braziliensis and its potential for the clinical diagnosis of tegumentary and visceral leishmaniasis.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Ronaldo Alves Pinto Nagem; Thaís Teodoro de Oliveira Santos; Ana Luíza Teixeira Silva; Marcelo Matos Santoro; Silvio Fernando Guimarães de Carvalho; Eduardo Antônio Ferraz Coelho; Daniella Castanheira Bartholomeu; Ricardo Toshio Fujiwara
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

9.  Novel recombinant multiepitope proteins for the diagnosis of asymptomatic leishmania infantum-infected dogs.

Authors:  Angélica Rosa Faria; Luciano de Castro Veloso; Wendel Coura-Vital; Alexandre Barbosa Reis; Leonardo Miranda Damasceno; Ricardo T Gazzinelli; Hélida M Andrade
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

10.  Regulation of Leishmania (L.) amazonensis protein expression by host T cell dependent responses: differential expression of oligopeptidase B, tryparedoxin peroxidase and HSP70 isoforms in amastigotes isolated from BALB/c and BALB/c nude mice.

Authors:  Priscila Camillo Teixeira; Leonardo Garcia Velasquez; Ana Paula Lepique; Eloiza de Rezende; José Matheus Camargo Bonatto; Marcello Andre Barcinski; Edecio Cunha-Neto; Beatriz Simonsen Stolf
Journal:  PLoS Negl Trop Dis       Date:  2015-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.